• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Apimeds Pharmaceuticals US, Inc. Common Stock (NY:APUS)

    7.180 +0.890 (+14.15%)
    Streaming Delayed Price Updated: 2:16 PM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Apimeds Pharmaceuticals US, Inc. Common Stock

    < Previous 1 2 Next >
    CryptoNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Launches MindChain, Announces U.S. Listing for NILA Token
    Via CryptoCurrencyWire
    CryptoNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Launches MindChain, Announces U.S. Listing for NILA Token
    Via Investor Brand Network
    TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Bridging Gap Between Traditional Finance and Web3
    Via Investor Brand Network
    Topics Artificial Intelligence
    The Next Generation of Treasury Management: How MindWave Innovations Inc. (NYSE American: APUS) Is Building for Programmable Corporate Reserves
    Via Investor Brand Network
    Topics Bonds
    MissionIRNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Advancing Platform for Institutional Bitcoin Treasury Strategies
    Via Investor Brand Network
    Bridging Traditional Finance and Web3: MindWave Innovations Inc.’s (NYSE American: APUS) Vision for Corporate Digital Asset Treasuries
    Via Investor Brand Network
    Topics Economy
    TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Integrates AI, Blockchain to Optimize Digital Asset Treasury Management
    Via Investor Brand Network
    Topics Artificial Intelligence Economy
    From Ownership to Utility: How Digital Assets Are Becoming Productive Capital
    Via CryptoCurrencyWire
    From Ownership to Utility: How Digital Assets Are Becoming Productive Capital
    Via Investor Brand Network
    MissionIRNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Offers Secure Gateway to Digital Assets
    Via Investor Brand Network
    MindWave Innovations Inc. (NYSE American: APUS) Is Building an Ecosystem Designed to Unlock the Full Potential of Digital Asset Treasury Management
    Via Investor Brand Network
    Topics Artificial Intelligence Economy
    TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Taps Growing Demand for Yield-Generating Solutions
    Via Investor Brand Network
    MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Bridge for Bitcoin Treasury Adoption
    Via Investor Brand Network
    Topics Economy
    Bitcoin as a Corporate Treasury Asset: How MindWave Innovations Inc. (NYSE American: APUS) Is Redefining Institutional Yield Infrastructure
    Via Investor Brand Network
    Topics Artificial Intelligence Economy
    The Infrastructure Gap Behind Corporate Bitcoin Adoption
    Via Investor Brand Network
    News headline image
    Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS
    From The Rosen Law Firm, P.A.
    Via Business Wire
    MindWave Innovations Inc. (NYSE American: APUS) Is ‘One to Watch’
    Via CryptoCurrencyWire
    Topics Artificial Intelligence Economy
    MindWave Innovations Inc. (NYSE American: APUS) Is ‘One to Watch’
    Via Investor Brand Network
    Topics Artificial Intelligence Economy
    News headline image
    Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
    From Apimeds Pharmaceuticals US, Inc.
    Via GlobeNewswire
    News headline image
    Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
    From Apimeds Pharmaceuticals US, Inc. and Lōkahi Therapeutics, Inc.
    Via Business Wire
    News headline image
    Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist College of Business
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    News headline image
    Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
    From Apimeds Pharmaceuticals US, Inc.
    Via Business Wire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.